These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 3753407)

  • 61. Platelet support and the use of cytokines.
    Bishop JF
    Stem Cells; 1994 Jul; 12(4):370-7. PubMed ID: 7524892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The current status and problems associated with platelet transfusion].
    Kimura A
    Rinsho Byori; 1982 Oct; 30(10):1074-80. PubMed ID: 7182580
    [No Abstract]   [Full Text] [Related]  

  • 64. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective transfusion of blood components.
    McCredie KB
    Int Adv Surg Oncol; 1981; 4():145-71. PubMed ID: 7019094
    [No Abstract]   [Full Text] [Related]  

  • 67. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylactic platelet transfusion in acute leukemia: which threshold should be used.
    Finazzi G
    Haematologica; 1998 Nov; 83(11):961-2. PubMed ID: 9864912
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effect of transfusion of various doses of thrombocyte mass in experimental drug-induced thrombocytopenia].
    Abesadze AI; Glonti AO; Kvernadze MG; Mosidze MA; Shelegiia ShIa
    Gematol Transfuziol; 1988 Nov; 33(11):27-30. PubMed ID: 3234723
    [No Abstract]   [Full Text] [Related]  

  • 71. Transfusion support for leukaemia and oncology patients.
    Mayer K
    Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084
    [No Abstract]   [Full Text] [Related]  

  • 72. [Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia].
    Andreu G; Benbunan M; Boasson M; Bussel A; Cordonnier C; Dosquet P; Marie JP; Miclea JM; Monconduit M; Norol F
    Nouv Rev Fr Hematol (1978); 1994; 35(6):517-22. PubMed ID: 8152897
    [No Abstract]   [Full Text] [Related]  

  • 73. [Evaluation of platelet transfusion].
    Fujiwara Y; Furukawa K; Tanaka M; Tanaka S; Nakade Y
    Rinsho Ketsueki; 1978 Oct; 19(10):1417-21. PubMed ID: 739601
    [No Abstract]   [Full Text] [Related]  

  • 74. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage.
    Witzig TE; Ducatman BS; Wick MR; Letendre L; Moore SB; Ilstrup DM; Taswell HF
    Am J Hematol; 1985 Apr; 18(4):345-50. PubMed ID: 3976647
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blood: use and abuse of whole blood and fractions.
    Saidi P
    Clin Ther; 1983; 5(4):327-34. PubMed ID: 6871916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rationale for blood component therapy.
    Steinbronn K; Huestis DW
    Contemp Anesth Pract; 1983; 6():151-67. PubMed ID: 6337017
    [No Abstract]   [Full Text] [Related]  

  • 77. Changes in serial platelet counts following massive blood transfusion in pediatric patients.
    Coté CJ; Liu LM; Szyfelbein SK; Goudsouzian NG; Daniels AL
    Anesthesiology; 1985 Feb; 62(2):197-201. PubMed ID: 3970376
    [No Abstract]   [Full Text] [Related]  

  • 78. Transfusion of fresh platelet concentrates to adult patients with thrombocytopenia.
    Cavins JA; Farber S; Roy AJ
    Transfusion; 1968; 8(1):24-7. PubMed ID: 5236033
    [No Abstract]   [Full Text] [Related]  

  • 79. Identification & management of defects in platelet hemostasis in massively transfused patients.
    Slichter SJ
    Prog Clin Biol Res; 1982; 108():225-58. PubMed ID: 6757960
    [No Abstract]   [Full Text] [Related]  

  • 80. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.